mh

90 posts

The 1918/20 Pandemic Mattered for Stock Prices

Marco Del Angel, Caroline Fohlin, Marc D. Weidenmier: Do Global Pandemics Matter for Stock Prices? Lessons from the 1918 Spanish Flu, in: NBER Working Paper Series, Working Paper 28356, January 2021, DOI: 10.3386/w28356.

The authors examine the impact of the 1918 “Spanish” flu on stock prices in the United States.

Continue reading

Influences of interventions and socioeconomic factors.

Rabail Chaudhry, George Dranitsaris, Talha Mubashir, Justyna Bartoszko, Sheila Riazi: A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes, in: EClinicalMedicine 25 (2020) 100464, DOI: https://doi.org/10.1016/j.eclinm.2020.100464.

The authors conducted a country-level exploratoy analysis to assess the impact of timing and nature of national health policies or actions taken on COVID-19 mortality and related health outcomes.

Continue reading

Oxfam Inequalitiy Report

Oxfam Deutschland e.V. (Ed.): Das Ungleichheitsvirus. Wie die Corona-Pandemie soziale Ungleichheit verschärft und warum wir unsere Wirtschaft gerechter gestalten müssen (The Inequality Virus. How the Corona Pandemic Exacerbates Social Inequality and Why We Need to Make Our Economy Fairer), Berlin, January 2021.

Ahead of the World Economic Forum, Oxfam publishes the report “The Inequality Virus.” The report shows how the Corona pandemic is exacerbating social inequality and why the solution lies in a just economic system.

Continue reading

Mortality and Adaptation Options

Quentin De Larochelambert, Andy Marc, Juliana Antero, Eric Le Bourg, Jean-François Toussaint: Covid-19 Mortality: A Matter of Vulnerability Among Nations Facing Limited Margins of Adaptation, in: Frontiers in Public Health, Vol. 8, Artikel 604339, November 2020.

Continue reading

Thesis Paper 7.0

Matthias Schrappe, Hedwig François-Kettner, Matthias Gruhl, Dieter Hart, Franz Knieps, Philip Manow, Holger Pfaff, Klaus Püschel, Gerd Glaeske: Thesenpapier 7. Die Pandemie durch SARS-CoV-2/CoViD-19. Sorgfältige Integration der Impfung in eine umfassende Präventionsstrategie. Impfkampagne resilient gestalten und wissenschaftlich begleiten. Aufklärung und Selbstbestimmung beachten, thesis paper version 7, final version Cologne, Berlin, Bremen, Hamburg January 10, 2021. (Thesis Paper 7. The Pandemic by SARS-CoV-2/CoViD-19. Carefully Integrating Vaccination into a Comprehensive Prevention Strategy. Make vaccination campaign resilient and provide scientific support. Respect education and self-determination).

Continue reading

The impact of the lockdown: Four Pre-studies

Andrew Atkeson, Karen Kopecky, Tao Zha: Four Stylized Facts about COVID-19, in: NBER Working Paper Series, Working Paper 27719 (August 2020), DOI 10.3386/w27719.

The authors document four facts about the COVID-19 pandemic worldwide relevant for those studying the impact of non-pharmaceutical interventions (NPIs) on COVID-19 transmission.

Continue reading

Moderna vaccine

Arznei-Telegramm: Neu auf dem Markt. Covid-19-Impfstoff von Moderna, in: arznei-telegramm, No. 52 (January 22, 2021), pp. 1-4.

In this issue of arznei-telegramm, the authors deal with the Covid-19 vaccine from the company Moderna.

Continue reading

Vaccines – hope or risk?

Arznei-Telegramm: Im Blickpunkt. Impfstoffe gegen Covid-19. Anlass zur Hoffnung oder unkalkulierbares Risiko?, in: arznei-telegramm Nr. 51 (18. Dezember 2020), pp. 89-92. (In Focus. Vaccines against Covid-19: Cause for hope or incalculable risk?).

In the December issue of arznei-telegramm, the authors of this article discussed the hopes for an effective vaccine that could help contain the pandemic, and the risks that these fast-track vaccines could pose.

Continue reading

Vaccines – state of knowledge unsatisfactory

BUKO Pharma-Kampagne (ed.): Nutzen von Covid-19 Impfungen. Wissensstand noch unbefriedigend, in: Pharma-Brief 10, December 2020. (Benefits of Covid-19 vaccinations. State of knowledge still unsatisfactory.)

In its article, BUKO Pharma-Kampagne addresses the issue of vaccines against the coronavirus.

“Several vaccines against covid-19 are close to approval or have already received emergency approval. But what do we even know about benefits and risks? The media reports high vaccine efficacy of 90% or more. The reports suggest that this means preventing severe disease and interrupting transmission of Covid-19. This is a misunderstanding, probably triggered by the fact that the figures circulating were based largely on brief press releases from the manufacturers, not on independently peer-reviewed scientific publications about the vaccines.”

Continue reading

World Bank Report

World Bank Group (ed.): Poverty and Shared Prosperity 2020: Reversals of Fortune. Washington, DC: World Bank, 2020.

The Poverty and Shared Prosperity series provides a global audience with the latest and most accurate estimates on trends in global poverty and shared prosperity. For more than two decades, extreme poverty was steadily declining. Now, for the first time in a generation, the quest to end poverty has suffered its worst setback.

Continue reading

Social protection in developing countries

International Labour Oraganization (ILO): Social protection responses to the COVID-19 pandemic in developing countries: Strengthening resilience by building universal social protection, May 14, 2020.

Social protection is an indispensable mechanism for delivering support to individuals during the crisis. This document takes a detailed look at the role of social protection measures in addressing the COVID-19 outbreak in developing countries.

Continue reading

Poverty Reduction Strategies

Briefing Note of the Overseas Development Institute (ODI)

Marcus Manuel, Liam Carson, Emma Samman and Martin Evan: Financing the reduction of extreme poverty post-Covid-19, November 2020.

The Covid-19 pandemic has wiped out years of progress in ending extreme poverty: we forecast an additional 250 million people in extreme poverty by 2030 and expect that it will take 10 years of economic growth just to bring extreme poverty numbers back to where they were before the crisis.

Continue reading

Affects on inequality

Davide Furceri, Prakash Loungani, Jonathan D. Ostry and Pietro Pizzuto: Will Covid-19 affect inequality? Evidence from past pandemics, in: CEPR Press, Issue 12, Mai 1, 2020, p. 138-157.

Continue reading

Seesen Appeal

The ver.di team delegates (Vereinigte Dienstleistungsgewerkschaft: United Services Trade Union) at the Askleipos Clinic in Seesen (Germany) are positioning themselves against the ruthless profit maximization by the commercial hospital group Askleipos and are fighting for the best possible patient care. Endorsed by solidary, prominent first supporters, they are looking for further supporters to join their demands.

Link to the appeal as PDF file

The Justinianic Plague

Forum: Zeiterfahrung: Mischa Meier: Die Justinianische Pest – im Spiegel der Covid-19-Pandemie betrachtet (The Justinianic Plague – seen in the mirror of the Covid 19 pandemic), in: H-Soz-Kult, 27.11.2020, online in: https://www.hsozkult.de/debate/id/diskussionen-5077 (Stand: 14.12.2020).

Based on the basic assumption that the experience of the Covid-19 pandemic has framed the subjects of his own research in a new way, the author of the article examines the Justinianic Plague on the basis of four texts from late antiquity and with the help of a theoretical model of the Tübingen Sonderforschungsbereich 923 “Bedrohte Ordnungen” (Collaborative Research Centre (CRC) 923 “Threatened Order – Societies under Stress”). The author is concerned with the question of how his own experience of a pandemic changed his view of the historical material. The focus here is less on analysis than on “collecting impressions” that have resulted from the new framing.

Continue reading